Oncotelic Therapeutics, Inc. [OTLC]

Source: 

Company Overview

Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer. After the acquisition of Mateon Therapeutics, Inc through a reverse merger in 2019, we realigned the company pipeline to focus on rare pediatric cancers.